Novartis signs macrocyclic deal with Unnatural Products for $100M upfront / Endpoints

Kyle LaHucik / endpoints - Novartis will pay $100 million upfront to tap into a macrocyclic peptide platform from Unnatural Products, a deal that could lead to new cardiovascular disease medicines. The move allows the Swiss pharma giant to delve ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment

Novartis Commits $100M to Startup With Tech That Brings Peptides to Undruggable Targets

19 days / medcitynews / Frank Vinluan

Novartis signs macrocyclic deal with Unnatural Products for $100M upfront

21 days / endpoints / Kyle LaHucik

Saturday, February 21, 2026, 6:22 am / permalink 19517 / 2 stories in 18 days

Related Stories

Sanofi ousts Paul Hudson as Belén Garijo named incoming CEO / 25 days
AstraZeneca Secures Pan‑KRAS Inhibitor Deal with Jacobio Pharma / 2 months
Servier to acquire Day One Biopharma for $2.5B / 4 days
Novartis closes Avidity deal; Atrium Therapeutics spinout launches / 9 days
Eli Lilly buys Orna to sprint into in‑vivo CAR‑T therapeutics / 25 days
Merck Eyes $30B Deal for Revolution Medicines Acquisition / 1 month
Merck acquires Cidara’s preventive flu drug for $9.2B / 3 months

Related Tags

Healthcare

Judge orders Leapfrog to remove safety grades for five Florida hospitals (21 hrs)

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis (40 hrs)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

more #healthcare

Pharmaceuticals

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

White House briefing triggered rapid drops in acetaminophen use in ERs (2 days)

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage (3 days)

more #pharmaceuticals

Biotech

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity (2 days)

Cancer Grand Challenges awards five teams bold funding for cancer research (3 days)

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes (4 days)

StackHealth Time Machine

NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.